FindTrial
Sign In

Study on evaluation of a tool named perfusion index to assess effectiveness of pain medication dexmedetomidine in reducing pain during laparoscopic gall bladder removal surgery under general anaesthesia

Study on evaluation of perfusion index as a tool to assess the analgesic efficacy of dexmedetomidine during laparoscopic cholecystectomy under general anaesthesia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060025
Enrollment
60
Registered
2023-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil

Sponsors

Amala Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Physical state ASA 1-2 Age group 18 years to 70 years Patients undergoing elective laparoscopic cholecystectomy surgeries under General anaesthesia

Exclusion criteria

Exclusion criteria: Patients not willing to participate in this study History of allergy to the drugs in the study Patients with neurological or psychiatric illness,chronic pain disorder

Design outcomes

Primary

MeasureTime frame
Primary outcome - incidence and severity of intra-op pain stimulus assessed using perfusion index toolTimepoint: Before induction,after induction,after intubation,1,2,3,2,4,6,8,10,15,20,25,30 minutes—

Secondary

MeasureTime frame
Comparison of perfusion index with hemodynamic parameters like heart rate, systolic blood pressure, diastolic blood pressure and mean arterial pressureTimepoint: Before induction, after induction, after intubation,1,2,3,2,4,6,8,10,15,20,25,30 minutes—

Countries

India

Contacts

Public ContactDr Derlin Thomas

Amala Institute of Medical Sciences

derlin.t@gmail.com9447768944

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026